APA (7th ed.) Citation

T, M., M, K., R, W., S, H., M, H., M, N., . . . J, H. (2018). Clostridium butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial. Clinical neuropharmacology, 41(5), 151. https://doi.org/10.1097/WNF.0000000000000299

Chicago Style (17th ed.) Citation

T, Miyaoka, et al. "Clostridium Butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial." Clinical Neuropharmacology 41, no. 5 (2018): 151. https://doi.org/10.1097/WNF.0000000000000299.

MLA (9th ed.) Citation

T, Miyaoka, et al. "Clostridium Butyricum MIYAIRI 588 as Adjunctive Therapy for Treatment-Resistant Major Depressive Disorder: A Prospective Open-Label Trial." Clinical Neuropharmacology, vol. 41, no. 5, 2018, p. 151, https://doi.org/10.1097/WNF.0000000000000299.